<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7394146</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32727853</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7394146</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">openhrt-2020-001315</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1136/openhrt-2020-001315</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Characteristics of the sample</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of the sample</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="2">MVA</td><td align="left" valign="bottom" rowspan="1" colspan="2">TTS</td><td align="left" valign="bottom" rowspan="1" colspan="2">AMI</td><td align="left" valign="bottom" rowspan="1" colspan="1">CHI2</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="8">General</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Mean age</td><td align="char" char="." rowspan="1" valign="top" colspan="1">68.8</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" valign="top" colspan="1">71.1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" valign="top" colspan="1">65.8</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">P=0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Sex (female)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">93.8%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">94.1%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">82.4%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Retired</td><td align="char" char="." rowspan="1" valign="top" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">87.5%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">94.1%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">76.5%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.326</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Right handed</td><td align="char" char="." rowspan="1" valign="top" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">100.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">100.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">100.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Time from TTS or AMI (months)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">44.6±20.2</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">80.0±54.9</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Angina CCS class (maximal)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> I</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.6%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> II</td><td align="char" char="." rowspan="1" valign="top" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">41.2%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> III</td><td align="char" char="." rowspan="1" valign="top" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">17.6%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> IV</td><td align="char" char="." rowspan="1" valign="top" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">41.2%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Angina during</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Emotional stress</td><td align="char" char="." rowspan="1" valign="top" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">17.6%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Environmental exposure</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Angina frequency</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Daily</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> &lt;1/weekly</td><td align="char" char="." rowspan="1" valign="top" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">58.8%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.6%</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> &gt;1/weekly</td><td align="char" char="." rowspan="1" valign="top" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">29.4%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NYHA class</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> I</td><td align="char" char="." rowspan="1" valign="top" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">76.5%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.1%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> II</td><td align="char" char="." rowspan="1" valign="top" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">23.5%</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"> </td><td align="char" char="." rowspan="1" valign="top" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">88.9%</td><td align="left" valign="top" rowspan="1" colspan="1"> </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> LVEF (%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">58.0±10.1</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="8">Classic cardiovascular risk factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Hypertension</td><td align="char" char="." rowspan="1" valign="top" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">62.5%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">47.10%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">82.4%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Hyperlipidaemia</td><td align="char" char="." rowspan="1" valign="top" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">56.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">88.2%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">94.1%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.014*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Diabetes mellitus</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">6.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">23.5%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Active smoker</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">6.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Previous smoker</td><td align="char" char="." rowspan="1" valign="top" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">31.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">29.4%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">47.1%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Family history</td><td align="char" char="." rowspan="1" valign="top" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">75.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">52.9%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">82.4%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="8">Psychiatric medical history</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Known major depression</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Known anxiety disorder</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">23.5%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">11.8%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.11</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Known psychotic disorder</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="8">Psychotropic medications</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Antiepileptic</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.00%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Atypical neuroleptic</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">6.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.90%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.584</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Benzodiazepine</td><td align="char" char="." rowspan="1" valign="top" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">37.5%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">41.2%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">29.4%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.766</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Non-BDZ hypnotic</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">6.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">P=5.9%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.999</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SNRI</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.613</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SSRI</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">17.6%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">23.5%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> III generation neuroleptic</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Tricyclic antidepressant</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">6.3%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.584</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Typical neuroleptic</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">5.9%</td><td align="left" valign="top" rowspan="1" colspan="1">P=0.371</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> 5-HT1A partial agonist</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> IMAO</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0%</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1"><p>AMI, acute myocardial infarction; BDZ, benzodiazepine; CCS, Canadian cardiovascular society grading of angina; CHI2, CHI square test; 5-HT1A, serotonin 1A receptor; IMAO, monoamine oxidase inhibitors; LVEF, fractional left ventricular ejection fraction; MVA, microvascular angina; NA, not applicable; NYHA, New York Heart Association Functional Classification; SNRI, serotonin–norepinephrine reuptake inhibitors; SSRI, selective serotonin reuptake inhibitors; TTS, Takotsubo syndrome.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of the sample</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom"/><td align="left" valign="bottom" colspan="2">MVA</td><td align="left" valign="bottom" colspan="2">TTS</td><td align="left" valign="bottom" colspan="2">AMI</td><td align="left" valign="bottom">CHI2</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="8">General</td></tr><tr><td align="left" valign="top"> Mean age</td><td align="char" char="." valign="top">68.8</td><td align="left" valign="top"/><td align="char" char="." valign="top">71.1</td><td align="left" valign="top"/><td align="char" char="." valign="top">65.8</td><td align="left" valign="top"/><td align="left" valign="top">P=0.15</td></tr><tr><td align="left" valign="top"> Sex (female)</td><td align="char" char="." valign="top">15</td><td align="left" valign="top">93.8%</td><td align="char" char="." valign="top">16</td><td align="left" valign="top">94.1%</td><td align="char" char="." valign="top">14</td><td align="left" valign="top">82.4%</td><td align="left" valign="top">P=0.43</td></tr><tr><td align="left" valign="top"> Retired</td><td align="char" char="." valign="top">14</td><td align="left" valign="top">87.5%</td><td align="char" char="." valign="top">16</td><td align="left" valign="top">94.1%</td><td align="char" char="." valign="top">13</td><td align="left" valign="top">76.5%</td><td align="left" valign="top">P=0.326</td></tr><tr><td align="left" valign="top"> Right handed</td><td align="char" char="." valign="top">16</td><td align="left" valign="top">100.0%</td><td align="char" char="." valign="top">17</td><td align="left" valign="top">100.0%</td><td align="char" char="." valign="top">17</td><td align="left" valign="top">100.0%</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> Time from TTS or AMI (months)</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="left" valign="top"/><td align="left" valign="top">44.6±20.2</td><td align="left" valign="top"/><td align="left" valign="top">80.0±54.9</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top">Angina CCS class (maximal)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> I</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.6%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> II</td><td align="char" char="." valign="top">7</td><td align="left" valign="top">41.2%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> III</td><td align="char" char="." valign="top">3</td><td align="left" valign="top">17.6%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> IV</td><td align="char" char="." valign="top">7</td><td align="left" valign="top">41.2%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top">Angina during</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> Emotional stress</td><td align="char" char="." valign="top">3</td><td align="left" valign="top">17.6%</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> Environmental exposure</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top">Angina frequency</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> Daily</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"> &lt;1/weekly</td><td align="char" char="." valign="top">10</td><td align="left" valign="top">58.8%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.6%</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"> &gt;1/weekly</td><td align="char" char="." valign="top">5</td><td align="left" valign="top">29.4%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">NYHA class</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> I</td><td align="char" char="." valign="top">13</td><td align="left" valign="top">76.5%</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.1%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> II</td><td align="char" char="." valign="top">4</td><td align="left" valign="top">23.5%</td><td align="left" valign="top"/><td align="left" valign="top"> </td><td align="char" char="." valign="top">15</td><td align="left" valign="top">88.9%</td><td align="left" valign="top"> </td></tr><tr><td align="left" valign="top"> LVEF (%)</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="left" valign="top"/><td align="left" valign="top">NA</td><td align="left" valign="top"/><td align="left" valign="top">58.0±10.1</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top" colspan="8">Classic cardiovascular risk factors</td></tr><tr><td align="left" valign="top"> Hypertension</td><td align="char" char="." valign="top">10</td><td align="left" valign="top">62.5%</td><td align="char" char="." valign="top">8</td><td align="left" valign="top">47.10%</td><td align="char" char="." valign="top">14</td><td align="left" valign="top">82.4%</td><td align="left" valign="top">P=0.10</td></tr><tr><td align="left" valign="top"> Hyperlipidaemia</td><td align="char" char="." valign="top">9</td><td align="left" valign="top">56.3%</td><td align="char" char="." valign="top">15</td><td align="left" valign="top">88.2%</td><td align="char" char="." valign="top">16</td><td align="left" valign="top">94.1%</td><td align="left" valign="top">P=0.014*</td></tr><tr><td align="left" valign="top"> Diabetes mellitus</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">6.3%</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="char" char="." valign="top">4</td><td align="left" valign="top">23.5%</td><td align="left" valign="top">P=0.34</td></tr><tr><td align="left" valign="top"> Active smoker</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">6.3%</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="left" valign="top">P=0.83</td></tr><tr><td align="left" valign="top"> Previous smoker</td><td align="char" char="." valign="top">5</td><td align="left" valign="top">31.3%</td><td align="char" char="." valign="top">5</td><td align="left" valign="top">29.4%</td><td align="char" char="." valign="top">8</td><td align="left" valign="top">47.1%</td><td align="left" valign="top">P=0.5</td></tr><tr><td align="left" valign="top"> Family history</td><td align="char" char="." valign="top">12</td><td align="left" valign="top">75.0%</td><td align="char" char="." valign="top">9</td><td align="left" valign="top">52.9%</td><td align="char" char="." valign="top">14</td><td align="left" valign="top">82.4%</td><td align="left" valign="top">P=0.15</td></tr><tr><td align="left" valign="top" colspan="8">Psychiatric medical history</td></tr><tr><td align="left" valign="top"> Known major depression</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="left" valign="top">P=0.36</td></tr><tr><td align="left" valign="top"> Known anxiety disorder</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">4</td><td align="left" valign="top">23.5%</td><td align="char" char="." valign="top">2</td><td align="left" valign="top">11.8%</td><td align="left" valign="top">P=0.11</td></tr><tr><td align="left" valign="top"> Known psychotic disorder</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top" colspan="8">Psychotropic medications</td></tr><tr><td align="left" valign="top"> Antiepileptic</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.00%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> Atypical neuroleptic</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">6.3%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.90%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">P=0.584</td></tr><tr><td align="left" valign="top"> Benzodiazepine</td><td align="char" char="." valign="top">6</td><td align="left" valign="top">37.5%</td><td align="char" char="." valign="top">7</td><td align="left" valign="top">41.2%</td><td align="char" char="." valign="top">5</td><td align="left" valign="top">29.4%</td><td align="left" valign="top">P=0.766</td></tr><tr><td align="left" valign="top"> Non-BDZ hypnotic</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">6.3%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">P=5.9%</td><td align="left" valign="top">P=0.999</td></tr><tr><td align="left" valign="top"> SNRI</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="left" valign="top">P=0.613</td></tr><tr><td align="left" valign="top"> SSRI</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">3</td><td align="left" valign="top">17.6%</td><td align="char" char="." valign="top">4</td><td align="left" valign="top">23.5%</td><td align="left" valign="top">P=0.13</td></tr><tr><td align="left" valign="top"> III generation neuroleptic</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> Tricyclic antidepressant</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">6.3%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">P=0.584</td></tr><tr><td align="left" valign="top"> Typical neuroleptic</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">1</td><td align="left" valign="top">5.9%</td><td align="left" valign="top">P=0.371</td></tr><tr><td align="left" valign="top"> 5-HT1A partial agonist</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top"> IMAO</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="char" char="." valign="top">0</td><td align="left" valign="top">0.0%</td><td align="left" valign="top">NA</td></tr></tbody></table></div>AMI, acute myocardial infarction; BDZ, benzodiazepine; CCS, Canadian cardiovascular society grading of angina; CHI2, CHI square test; 5-HT1A, serotonin 1A receptor; IMAO, monoamine oxidase inhibitors; LVEF, fractional left ventricular ejection fraction; MVA, microvascular angina; NA, not applicable; NYHA, New York Heart Association Functional Classification; SNRI, serotonin–norepinephrine reuptake inhibitors; SSRI, selective serotonin reuptake inhibitors; TTS, Takotsubo syndrome.</transformed-table></extracted-table></extracted-tables-set>